These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26891276)

  • 1. Selective Inhibition of Aggregation and Toxicity of a Tau-Derived Peptide using Its Glycosylated Analogues.
    Frenkel-Pinter M; Richman M; Belostozky A; Abu-Mokh A; Gazit E; Rahimipour S; Segal D
    Chemistry; 2016 Apr; 22(17):5945-52. PubMed ID: 26891276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct Effects of O-GlcNAcylation and Phosphorylation of a Tau-Derived Amyloid Peptide on Aggregation of the Native Peptide.
    Frenkel-Pinter M; Richman M; Belostozky A; Abu-Mokh A; Gazit E; Rahimipour S; Segal D
    Chemistry; 2018 Sep; 24(53):14039-14043. PubMed ID: 30144161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of tau aggregation using a naturally-occurring cyclic peptide scaffold.
    Wang CK; Northfield SE; Huang YH; Ramos MC; Craik DJ
    Eur J Med Chem; 2016 Feb; 109():342-9. PubMed ID: 26807864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How post-translational modifications influence amyloid formation: a systematic study of phosphorylation and glycosylation in model peptides.
    Broncel M; Falenski JA; Wagner SC; Hackenberger CP; Koksch B
    Chemistry; 2010 Jul; 16(26):7881-8. PubMed ID: 20491120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the Aggregation and Toxicity of the Minimal Amyloidogenic Fragment of Tau by Its Pro-Substituted Analogues.
    Chemerovski-Glikman M; Frenkel-Pinter M; Mdah R; Abu-Mokh A; Gazit E; Segal D
    Chemistry; 2017 Jul; 23(40):9618-9624. PubMed ID: 28544138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbamylation promotes amyloidogenesis and induces structural changes in Tau-core hexapeptide fibrils.
    Guru KrishnaKumar V; Baweja L; Ralhan K; Gupta S
    Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2590-2604. PubMed ID: 30071272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrocyclic β-sheet peptides that inhibit the aggregation of a tau-protein-derived hexapeptide.
    Zheng J; Liu C; Sawaya MR; Vadla B; Khan S; Woods RJ; Eisenberg D; Goux WJ; Nowick JS
    J Am Chem Soc; 2011 Mar; 133(9):3144-57. PubMed ID: 21319744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating in vitro and in silico approaches to evaluate the "dual functionality" of palmatine chloride in inhibiting and disassembling Tau-derived VQIVYK peptide fibrils.
    Haj E; Losev Y; Guru KrishnaKumar V; Pichinuk E; Engel H; Raveh A; Gazit E; Segal D
    Biochim Biophys Acta Gen Subj; 2018 Jul; 1862(7):1565-1575. PubMed ID: 29634991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective suppression of the modified PHF6 peptide/1N4R Tau amyloid aggregation by intact curcumin, not its degradation products: Another evidence for the pigment as preventive/therapeutic "functional food".
    Bijari N; Balalaie S; Akbari V; Golmohammadi F; Moradi S; Adibi H; Khodarahmi R
    Int J Biol Macromol; 2018 Dec; 120(Pt A):1009-1022. PubMed ID: 30172816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disclosing the Mechanism of Spontaneous Aggregation and Template-Induced Misfolding of the Key Hexapeptide (PHF6) of Tau Protein Based on Molecular Dynamics Simulation.
    Liu H; Zhong H; Liu X; Zhou S; Tan S; Liu H; Yao X
    ACS Chem Neurosci; 2019 Dec; 10(12):4810-4823. PubMed ID: 31661961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positional effects of phosphorylation on the stability and morphology of tau-related amyloid fibrils.
    Inoue M; Konno T; Tainaka K; Nakata E; Yoshida HO; Morii T
    Biochemistry; 2012 Feb; 51(7):1396-406. PubMed ID: 22304362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsp90 directly interacts, in vitro, with amyloid structures and modulates their assembly and disassembly.
    Schirmer C; Lepvrier E; Duchesne L; Decaux O; Thomas D; Delamarche C; Garnier C
    Biochim Biophys Acta; 2016 Nov; 1860(11 Pt A):2598-2609. PubMed ID: 27495389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection and Characterization of Tau Binding ᴅ-Enantiomeric Peptides with Potential for Therapy of Alzheimer Disease.
    Dammers C; Yolcu D; Kukuk L; Willbold D; Pickhardt M; Mandelkow E; Horn AH; Sticht H; Malhis MN; Will N; Schuster J; Funke SA
    PLoS One; 2016; 11(12):e0167432. PubMed ID: 28006031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational preferences of an amyloidogenic peptide: IR spectroscopy of Ac-VQIVYK-NHMe.
    Vaden TD; Gowers SA; de Boer TS; Steill JD; Oomens J; Snoek LC
    J Am Chem Soc; 2008 Nov; 130(44):14640-50. PubMed ID: 18844349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A hydrophobic surface is essential to inhibit the aggregation of a tau-protein-derived hexapeptide.
    Zheng J; Baghkhanian AM; Nowick JS
    J Am Chem Soc; 2013 May; 135(18):6846-52. PubMed ID: 23627648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane-mediated fibrillation and toxicity of the tau hexapeptide PHF6.
    Fanni AM; Vander Zanden CM; Majewska PV; Majewski J; Chi EY
    J Biol Chem; 2019 Oct; 294(42):15304-15317. PubMed ID: 31439664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naphthoquinone-Tryptophan Hybrid Inhibits Aggregation of the Tau-Derived Peptide PHF6 and Reduces Neurotoxicity.
    Frenkel-Pinter M; Tal S; Scherzer-Attali R; Abu-Hussien M; Alyagor I; Eisenbaum T; Gazit E; Segal D
    J Alzheimers Dis; 2016; 51(1):165-78. PubMed ID: 26836184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can molecular dynamics simulations assist in design of specific inhibitors and imaging agents of amyloid aggregation? Structure, stability and free energy predictions for amyloid oligomers of VQIVYK, MVGGVV and LYQLEN.
    Berhanu WM; Masunov AE
    J Mol Model; 2011 Oct; 17(10):2423-42. PubMed ID: 21174134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of nucleating sequences from amyloidogenic propensities of tau-related peptides.
    Rojas Quijano FA; Morrow D; Wise BM; Brancia FL; Goux WJ
    Biochemistry; 2006 Apr; 45(14):4638-52. PubMed ID: 16584199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High level of aspartic acid-bond isomerization during the synthesis of an N-linked tau glycopeptide.
    Hoffmann R; Craik DJ; Bokonyi K; Varga I; Otvos L
    J Pept Sci; 1999 Oct; 5(10):442-56. PubMed ID: 10580643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.